• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ALA

AROVELLA THERAPEUTICS LIMITED

0.00% ! 7.5¢
Market Cap $90.65M  !

Arovella Therapeutics Limited is a biotechnology company. The Company is focused on... Arovella Therapeutics Limited is a biotechnology company. The Company is focused on developing its invariant natural killer T (iNKT) cell therapy platform from Imperial College London to treat blood cancers and solid tumors. The Company's lead product is ALA-101. ALA-101 is being developed as an allogeneic cell therapy, which means it can be given from a healthy donor to a patient. ALA-101 is a next-generation CAR-iNKT cell therapy that targets CD19+ B cell lymphomas and leukemias. ALA-101 consists of CAR19-iNKT cells that have been modified to produce a Chimeric Antigen Receptor (CAR) that targets CD19. CD19 is an antigen found on the surface of numerous cancer types. The Company is also engaged in expanding solid tumor treatment through its CLDN18.2-targeting technology licensed from Sparx Group. Its iNKT cells also contain an invariant T cell receptor (iTCR) that targets alpha-galactosylceramide (a-GalCer) bound CD1d, another antigen found on the surface of several cancer types.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ALA 14/05/26 29 9.4K
14/05/26 Last post  JD258 Comments Created with Sketch.  29  Views Created with Sketch.  9.4K 
ALA 13/05/26 7 2.2K
13/05/26 Last post  Jacko62 Comments Created with Sketch.  7  Views Created with Sketch.  2.2K 
ALA 07/05/26 10 2.9K
07/05/26 Last post  GazBusey Comments Created with Sketch.  10  Views Created with Sketch.  2.9K 
ALA 07/05/26 0 246
07/05/26 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  246 
ALA 07/05/26 0 174
07/05/26 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  174 
ALA 05/05/26 17 4.3K
05/05/26 Last post  Uttsy Comments Created with Sketch.  17  Views Created with Sketch.  4.3K 
ALA 29/04/26 4 2K
29/04/26 Last post  Bluebush Comments Created with Sketch.  4  Views Created with Sketch.  2K 
ALA 28/04/26 0 347
28/04/26 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  347 

See All Discussions arrow Created with Sketch.

Timeline

Notification of cessation of securities - ALA
08 May 08:33
 
Final Director's Interest Notice x4
07 May 10:20
 
Arovella Presents at ISCT Conference in Dublin
07 May 08:30
 
Arovella Appoints Acting CEO
07 May 08:24
 
Board Refresh and CEO Resignation
04 May 10:00
 
Initial Director's Interest Notice x4
01 May 10:22
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
Last
7.5¢
Change
0.000(0.00%)
Mkt cap ! $90.65M
Open High Low Volume
7.5¢ 7.6¢ 7.5¢ 448.9K

Buyers (Bids)

Vol. Price($)
100388 7.4¢
 

Sellers (Offers)

Price($) Vol.
7.5¢ 24189
Last trade - 15.59pm 15/05/2026 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.